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• Ypk1 and PKA activate trehalase activity of Nth1.
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Protein phosphorylation cascades play a central role in
the regulation of cell growth and protein kinases PKA,
Sch9 and Ypk1 take center stage in regulating this proc-
ess in S. cerevisiae. To understand how these kinases
co-ordinately regulate cellular functions we compared the
phospho-proteome of exponentially growing cells without
and with acute chemical inhibition of PKA, Sch9 and Ypk1.
Sites hypo-phosphorylated upon PKA and Sch9 inhibition
were preferentially located in RRxS/T-motifs suggesting
that many are directly phosphorylated by these enzymes.
Interestingly, when inhibiting Ypk1 we not only detected
several hypo-phosphorylated sites in the previously re-
ported RxRxxS/T-, but also in an RRxS/T-motif. Validation
experiments revealed that neutral trehalase Nth1, a known
PKA target, is additionally phosphorylated and activated
downstream of Ypk1. Signaling through Ypk1 is therefore
more closely related to PKA- and Sch9-signaling than
previously appreciated and may perform functions previ-
ously only attributed to the latter kinases. Molecular &
Cellular Proteomics 19: 655–671, 2020. DOI: 10.1074/mcp.
RA120.001955.
Cell growth is dynamic and highly regulated by signaling
pathways that are conserved across evolution. To accomplish
this regulation, eukaryotes have developed intricate means to
assess growth conditions and to rapidly communicate this in-
formation to the processes controlling the accumulation of
mass, the modification of cellular volume and of membrane
surface area. Although many signal transduction pathways are
involved in this regulation, those employing AGC-family kinases
(named after Protein Kinases A, G and C) are prominent.
The target of rapamycin complexes 1 and 2 (TORC1 and
TORC2) are central sensors of environmental conditions and
regulators of cell growth (1). Both complexes exert their func-
tions by phosphorylating AGC-kinases as their main targets.
In S. cerevisiae TORC1 primarily responds to changes in
carbon and nitrogen availability and regulates ribosome bio-
genesis, cell cycle progression and stress responses via the
AGC-kinase Sch9, like S6K downstream of mammalian
TORC1 (1, 2).
Another AGC-kinase, protein kinase A (PKA)1, performs
many, if not most of its functions in parallel to Sch9 by
regulating an overlapping set of functions and potentially
by cross-talk (3–5). Indeed, Sch9 was originally identified by
virtue of its ability to suppress growth phenotypes associated
with loss of PKA activity (6). Reciprocally, hyper-activation of
PKA signaling can suppress phenotypes linked to the loss of
Sch9 activity (4).
Tpk1, Tpk2, and Tpk3 are the partially redundant paralogs
of the catalytic subunit of PKA. When cells are starved of
carbon, cAMP levels are low and, therefore, PKA is kept
inactive by its regulatory subunit Bcy1. Glucose addition in-
duces activation of the adenylate cyclase Cyr1/Cdc35 via the
small GTPase Ras1/2 and the G protein-coupled receptor
Gpr1. The subsequent increase in cAMP levels triggers the
dissociation of Bcy1 from the Tpks allowing them to phos-
phorylate their substrates (7, 8). Additionally, cAMP-inde-
pendent activation of PKA has been reported (9). In addition to
cell growth, Tpk effectors influence many other processes
including carbohydrate metabolism, cell cycle progression,
sporulation, pseudohyphal development and longevity by
controlling the activities of metabolic enzymes, transcription
and autophagy factors (10–13).
Similarly to TORC1, TORC2 phosphorylates and activates
AGC-kinases, including Ypk1 and its redundant paralog Ypk2,
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in their hydrophobic motif (14, 15). Deletion of YPK2 produces
no obvious phenotype suggesting that it only plays a minor
role in cell growth control (16). Recent work has demonstrated
that TORC2 is regulated downstream of membrane tension
(17), oxidative stress (18) and carbon cues (19). In turn, Ypk1,
which is homologous to the mTORC2 substrate SGK in hu-
mans (20, 21), couples TORC2 signals to the regulation of
membrane lipid biosynthesis and the regulation of cell surface
area.
Despite their central role in the regulation of fundamental
cellular processes and intense efforts in understanding the
functions controlled by these kinases, a systematic assess-
ment of their targets has been lacking to date. A previous
study aimed at systematically defining changes in the phos-
pho-proteome associated with the absence of protein ki-
nases, using kinase deletion strains (22). However, this ap-
proach is limited to the study of non-essential kinases and
allows cells to adapt to the absence of a kinase.
To overcome these limitations, we employed yeast strains
expressing analog-sensitive (23) variants of PKA, Sch9 and
Ypk1. Mutation of the gatekeeper residue of these kinases
allows binding of the bulky ATP-analog C3–1-naphthyl-
methyl PP1 (1NM-PP1), thus preventing ATP-binding and ren-
dering the enzymes inactive. Using this selective and acute
way of kinase inhibition, we explored the phospho-protein
targets downstream of each of these major AGC-kinases by
means of quantitative mass spectrometry. In these phospho-
proteomics data sets we identified both known and potentially
new targets of each tested kinase. As expected, we found
extensive substrate overlap between PKA and Sch9. Unex-
pected was our finding that several substrates were shared
between PKA and/or Sch9 and Ypk1 and that many sites
hypo-phosphorylated upon Ypk1 inhibition resided in an
RRxS/T-motif, which has previously been associated with
PKA and Sch9, rather than Ypk1.
Among the numerous potentially new kinase-substrate re-
lationships discovered in this study, we chose neutral tre-
halase Nth1 as a candidate for follow-up experiments. Nth1
has been employed as a model PKA-substrate in multiple
previous studies (24, 25). Trehalose is a disaccharide that
functions as a stress-protectant and reserve carbohydrate
under adverse conditions (26, 27). Upon return to favorable
conditions, trehalose is converted into two molecules of glu-
cose by trehalases, including the neutral trehalase Nth1 (25).
The regulation of Nth1 by PKA has long been recognized as
important for cell survival (24, 28). Here, we site-specifically
validated that Ypk1-, as well as PKA-inhibition reduced its
phosphorylation of an RRxS-site and showed that this is
associated with reduced trehalase activity.
These findings highlight the need for revisiting the Ypk1
consensus motif and prompt further investigation of the rela-
tionship of PKA and TORC1-Sch9 signaling on one hand and
TORC2-Ypk1 on the other hand.
EXPERIMENTAL PROCEDURES
Yeast Cultures and Assays—Saccharomyces cerevisiae strains
used in this study are listed in Table I. Strains were constructed using
standard yeast genetic manipulation (29).
Label-free Phospho-proteomics—Three replicates each of DMSO-
and 1NM-PP1- (Merck) treated sch9as, pkaas, pkaassch9as and
1 The abbreviations used are: PKA, Protein kinase A; AGC-kinases,
Protein kinases of the family comprising PKA, PKG and PKC; TORC1/
TORC2, TOR complex 1/2; 1NM-PP1, C3–1-naphthyl-methyl PP1;
FDR, false-discovery rate; GO, gene ontology; PSM, peptide spec-
trum match.
TABLE I
S. cerevisiae strains used in this study
Referred to as Genotype Name
pkaassch9as TB50a tpk1-M164G tpk2-M147G tpk3-M165G SCH9::sch9-T492G(pRS304)
ypk1::Kan ypk2::HphNT pRS416-YPK1wt
MPP88
pkaas TB50a tpk1-as tpk2-as tpk3-as SCH9::SCH9wt(pRS304) ypk1::Kan ypk2::HphNT
pRS416-YPK1wt
MPP86
sch9as TB50a Sch9::sch9-T492G(pRS304) ypk1::Kan ypk2::HphNT pRS416-YPK1-wt(791) MPP84
ypk1as TB50a SCH9::SCH9wt(pRS304) ypk1::Kan ypk2::HphNT pRS416-ypk1-L424G MPP91
pkaasypk1as TB50a tpk1-M164G tpk2-M147G tpk3-M165G SCH9::SCH9wt(pRS304) ypk1::Kan
ypk2::HphNT pRS416-ypk1-L424G
MPP87
wtas NTH1–3xFLAG TB50a SCH9::SCH9wt(pRS304) ypk1::Kan ypk2::HphNT pRS416-YPK1wt
NTH1–3xFLAG::HIS3
yMJP012
pkaas NTH1–3xFLAG TB50a tpk1-M164G tpk2-M147G tpk3-M165G SCH9::SCH9wt(pRS304) ypk1::Kan
ypk2::HphNT pRS416-YPK1wt NTH1–3xFLAG::HIS3
yMJP010
ypk1as NTH1–3xFLAG TB50a SCH9::SCH9wt(pRS304) ypk1::Kan ypk2::HphNT pRS416-ypk1-L424G
NTH1–3xFLAG::HIS3
yMJP009
pkaasypk1as NTH1–3xFLAG TB50a tpk1-M164G tpk2-M147G tpk3-M165G SCH9::SCH9wt(pRS304) ypk1::Kan
ypk2::HphNT pRS416-ypk1-L424G NTH1–3xFLAG::HIS3
yMJP040
wtas nth1–5A-3xFLAG TB50a SCH9::SCH9wt(pRS304) ypk1::Kan ypk2::HphNT pRS416-YPK1wt
nth1-S20A,S21A,T58A,S60A,S83A-3xFLAG::HIS3
yMJP033
nth1 TB50a SCH9::SCH9wt(pRS304) ypk1::Kan ypk2::HphNT pRS416-YPK1wt
nth1::NatNT2
yMJP013
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ypk1as cultures were prepared for label-free phospho-proteomics as
previously described (30). In brief, all cultures were diluted to OD 0.2
and grown to exponential phase (OD 0.7–0.8). Each strain was
treated with 500 nM 1NM-PP1 or DMSO for 15 min after which ice
cold 100% TCA was added to a final concentration of 6%. The
samples were incubated on ice for 30 min. After centrifugation the
cells were washed twice with acetone and kept at 70 °C.
Cell pellets were suspended in a buffer consisting of 8 M urea, 50
mM ammonium bicarbonate, and 5 mM EDTA, then lysed by bead
beating. For each biological replicate, 3 mg protein were reduced
using 5 mM TCEP, alkylated in 10 mM iodoacetamide, and digested
overnight with trypsin (1:125 w/w). Reverse phase chromatography
was used to purify samples before phospho-peptide enrichment,
which was performed with titanium dioxide resin (1.25 mg resin for
each sample) (22). Isolated phospho-peptides were analyzed on an
LTQ-Obritrap XL mass spectrometer (Thermo Scientific). A 90-min
gradient, starting with 3% and ending with 23% acetonitrile, was used
for liquid chromatography elution. The 4 most intense ions detected in
each MS1 measurement were selected for MS2 fragmentation.
The mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium via the PRIDE (31) partner repos-
itory with the data set identifier PXD015668 and 10.6019/PXD015668.
Data Analysis—Mass spectrometry data were processed with the
MaxQuant software (v. 1.6.0.16), which uses the Andomeda MS/MS
spectrum search engine (32, 33). The following search settings were
used: enzyme was Trypsin/P with 2 allowed missed cleavages. For
precursor ions the first search tolerance was set to 20 ppm and the
main search tolerance to 4.5 ppm and for fragment ions the tolerance
was set to 0.5 Th. Phosphorylation of serine, threonine and tyrosine
residues, oxidation of methionine, acetylation of protein N termini and
deamidation of asparagine and glutamine were used as variable
modifications (maximal 5 modifications per peptide). Carbamidom-
ethylation of cysteine was used as fixed modification. The SGD yeast
protein database (https://downloads.yeastgenome.org/sequence/
S288C_reference/orf_protein/orf_trans_all.fasta.gz; 6713 entries)
from 2015–01-13 was used to match the spectra. Finally, a peptide
and modification site FDR of 0.01 was applied to filter peptide spec-
trum matches (PSMs). Contaminants and decoys were subsequently
removed from the results.
The MaxQuant result tables (msms.txt for PSMs and positioning
information, modificationSpecificPeptides.txt for intensity values;
provided as supplemental Table S1 and S2 respectively) were im-
ported into the R statistical environment to perform missing value
imputation and intensity normalization. Only peptides containing at
least one phosphorylation were retained, together with all possible
positions of the phosphorylation and their respective scores. All in-
tensity values were log2 transformed (supplemental Table S3).
Supplemental Fig. S1A shows the occurrence of missing values
across the 3000 phospho-peptides revealing that certain peptides
and certain MS-runs are more prone to missing values. An example of
a peptide with missing values can be seen in supplemental Fig. S1B,
where all Sch9/PKA-1NM-PP1 values of the peptide HSS(ph)PDPY-
GINDKFFDLEK and one Sch9 and one PKA value are missing. In the
sibling peptide (see below) HSS(ph)PDPYGINDK with clearly higher
MS1 intensities all values are present (supplemental Fig. S1C). This
shows that even if all 3 replicates values are missing, one cannot
conclude absence of the corresponding peptide, but these missing
values are most likely artifacts inherent to MS1 based quantitation.
Phospho-peptides with no missing values in 3 replicates have stron-
ger average MS1 signal intensities compared with peptides with
missing values (supplemental Fig. S1D). If only one value out of 3
replicate values is missing, the 2 remaining positive replicate values
can be used to estimate or impute the missing values (see below).
However, if 2 or 3 values are missing, imputation becomes more error
prone and can easily lead to false positives, when searching for
peptides of differential abundance. Therefore, we only retained pep-
tides with maximally one missing value per 3 replicates. 67.3% of all
phospho-peptides fall in this category (supplemental Fig. S1E).
We imputed a missing log2-transformed intensity value IP,S,i of
peptide P in replicate i of sample S by
IP,S,i  P,S,i  ,  (1)
where P,S,i is the mean of the 2 non-missing values of peptide P in
sample S and ,  is a Gaussian error term with mean  and
standard deviation . In order to estimate this error term, we first need
the notion of sibling peptides. Two peptides are called siblings if the
sequence of one peptide is a N/C-terminal extension of the sequence
of the other one (i.e. they differ by a missed cleavage) and if they carry
the same modifications. It is unlikely that the sample condition has a
direct influence on the trypsin cleavage, and it can be expected that
two sibling peptides have similar expression profiles.
The imputation parameters  and  are then estimated using the
sibling peptides present in the MaxQuant results: for each peptide P
with a missing value in replicate i in sample S, we searched for sibling
peptides P’ of P with no missing values in the 3 replicates of sample
S. Then we calculated the difference between the IP’,S,i and P’,S,i and
used all these differences to estimate  and . The result shown in
supplemental Fig. S1F reveals that the missing values are on average
slightly, but significantly lower than the average of the 2 non-missing
values (t test p value of 0.003), a small bias that we took into account
in the imputation Eq. 1).
After missing value imputation, the R package limma (34) was used
for intensity normalization. First the normalizeBetweenArrays R-func-
tion was used to equalize the log2-intensity distributions in all 30
LC-MS runs. The lmFit function was used to remove eventual batch
effects present in the 10 samples. The empirical Bayes (eBayes)
method was the applied to compare the 1NM-PP1 treated to the
control (DMSO) samples for each strain and to calculate fold-changes
and p values adjusted for multiple testing (FDR adjustment) (supple-
mental Table S3). This method performs a correction of the standard
deviation of each peptide by the overall empirical standard deviation.
Generation of Sequence Logos—For each phospho-peptide that
exhibited a change upon treatment with an adjusted p value of less
than 0.05 the sequence from 5 to 5 amino acids from each of the
phospho-sites localized on the peptide was extracted. In case of
ambiguity between isoforms with different phospho-localizations, the
peptide with the best localization score was chosen. If a phospho-site
was represented by several peptides, the sequence surrounding the
site was listed only once. This was performed individually for each
strain for hyper- and hypo-phosphorylated peptides and the union of
both.
Sequence logos were generated with pLogo using all quantified
phospho-peptides as a background (35).
Sequence motifs of sites hypo-phosphorylated upon TORC2-inhi-
bition in Rispal et al., 2015 were based on sites in supplemental Table
S2 of that study and generated in an analogous manner (36).
Gene Ontology Analysis—For GO-analysis the systematic gene
names of proteins harboring phospho-sites significantly changing
upon kinase inhibition with an adjusted p value below 0.05 were used
as a foreground and harboring any quantified phospho-site as a
background. The analysis was performed using the “GO Term Finder”
tool at the Saccharomyces Genome Database at a p value of 0.05
with FDR calculation enabled (37).
The network of proteins associated with GO-term “Endocytosis” in
the Ypk1-data set was displayed in the STRING-database tool at
default parameters (38).
Experimental Design and Statistical Rationale—In the label-free
phospho-proteomics, targeted proteomics and the trehalase activity
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assay, the stated number of replicate cultures of analog-sensitive
strains or wt-strain (wtas) were treated with ATP-analog (1NM-PP1) or
mock (DMSO). Three replicates per strain were used for shotgun and
targeted proteomics and six replicates for the trehalase assay. Inde-
pendent starter cultures were used for each strain to generate repli-
cates. The number of replicates used is the highest number deemed
justified considering cost and the ability to process samples in par-
allel. No replication was used in Western blotting as the results were
verified by Parallel Reaction Monitoring (PRM) as an alternative
approach.
A strain which was not expected to be affected by 1NM-PP1
addition (wtas) was employed in all experiments. For Western blotting,
a strain not carrying a FLAG-tag and another in which five serines of
Nth1 had been mutated to alanine were used as additional controls.
For label-free phospho-proteomics, after data processing as de-
scribed above, the empirical Bayes (eBayes) method of the limma R
package (34) was then applied to compare the 1NM-PP1 treated to
the mock-treated samples for each strain and to calculate fold-
changes and p values adjusted for multiple testing (FDR adjustment).
Using this approach an observed false positive rate of 0.4% was
calculated based on the results from the wtas strain.
For targeted proteomics and the trehalase activity assay, 1NM-
PP1-treated samples were compared with mock-treated samples
using unpaired, two-sided Student’s t-tests for each strain.
When analyzing sets of data points, rather than individual data
points (e.g. phospho-sites), a trade-off exists between the quality with
which each point is measured and the number of points representing
each set. To achieve meaningful set-sizes we did not apply further
localization score thresholds when analyzing ensembles of phospho-
sites (e.g. for generating Venn-diagrams or sequence-logos), how-
ever, we ensured that sites are based on phospho-isoforms with the
highest localization score. As stated in the RESULTS-section, when
performing analyses on the level of individual phospho-sites we re-
quired the presence of sequence motifs as additional criteria.
Parallel Reaction Monitoring—Samples for targeted proteomics by
PRM were prepared from 250 g of protein in a similar manner as for
label-free phospho-proteomics, with the exception that a mixture of
magnetic TiO2, ZrO2 and Ti(IV)-IMAC beads (15 l each; ReSyn
Biosciences) were used for phospho-peptide enrichment, essentially
following the manufacturer’s instructions.
Data acquisition was performed on an Orbitrap Fusion Tribrid mass
spectrometer coupled to an nLC1000 uHPLC without use of internal
standard peptides (Tier 3). Peptides were separated on a 25 cm EASY-
spray column (Thermo Scientific) with a 30 min gradient from 3 to 25%
acetonitrile, 0.1% formic acid versus 0.1% formic acid in water. MS-
scans were acquired at 60 000 resolution, with an ion target of 4  105
and maximum injection time of 118 ms. Targeted MS/MS employing
higher energy collisional dissociation on 9 selected precursors repre-
senting Nth1 phospho-peptides and targeted single ion monitoring on
two precursors were each acquired at a resolution of 60,000 with an ion
target of 4  105 and maximum injection time of 200 ms.
For data analysis in Skyline 4.2.0.19072 we employed spectral
libraries from previously generated data-dependent acquisition and
filtered for seven b- or y-ions from ion 3 to last ion (39).
The extracted total areas were normalized to the total ion current area
of the corresponding sample and an intensity-weighted mean was
calculated for cases in which phospho-sites were represented by sev-
eral precursors. The significance of changes between DMSO- and
1NM-PP1 treated samples was evaluated using a two-sided Student’s
t test.
PRM data are accessible at ProteomeXchange via identifier
PXD015760.
Spot Assays—Yeast strains were inoculated in YPD (pH 5.6) and
incubated at 30 °C and 120 rpm overnight, diluted to OD 	 0.1 the
next morning and again to 0.0002 in the evening with incubation
under the same conditions. Once an OD of about 0.8 was reached
cultures were diluted to OD 0.08 and further in a 10x dilution series in
the same medium.
For spot assays 3 l of these cultures were spotted onto YPD agar
plates containing 500 nM 1NM-PP1 or an equal volume of DMSO and
incubated at 30 °C for 2 days.
Determination of Colony Sizes—Yeast strains were inoculated in
YPD (pH 5.6) and incubated at 30 °C and 120 rpm overnight, diluted
to OD 	 0.1, grown to an OD of about 0.8 and diluted to an OD of
0.00008. Of the diluted culture, 100 l were spread out with glass
beads on three YPD-plates per strain and incubated at 30 °C. After 2
days, images were taken and colony sizes quantified using ImageJ
(1.52p) (40): After splitting color channels, a threshold was applied to
the blue channel to distinguish colonies from background. For each
plate the area of colonies was determined using the “Analyze Parti-
cles” function set to 25–2000 pixels2 and 0.8–1.0 circularity. Over-
lapping colonies or colonies at the edge of plates were manually
excluded. The difference of colony sizes of analog-sensitive strains
compared with wtas was evaluated using the Mann-Whitney-Wilc-
oxon test.
Recombinant Protein Purification from S. cerevisiae Cultures—Wt
and analog-sensitive (Sch9-T492G, Ypk1-L424G) versions of GST-
tagged Sch9 and Ypk1 were expressed in BY4741 from uracil-select-
able plasmids employing galactose-inducible promoters: Strains
were inoculated in 5 ml SC-Ura  2% glucose and expanded in 200
ml SC-Ura  2% raffinose at 30 oC. Protein expression was induced
by addition of galactose to 2%. After 3 h, cells were spun down and
washed once with cold PBS before snap freezing and storage at -
80 °C.
Pellets were resuspended in 10 ml/g lysis buffer (PBS with 10%
glycerol, 5 mM CHAPS, Complete Protease Inhibitor Mixture, 1 mM
PMSF) and lysed using a French press (2 rounds, 1100 PSI). Lysates
were spun down for 20 min at 20,000  g and 4 °C. The supernatant
was incubated with 2 ml glutathione Sepharose 4B beads (GE Health-
care) for 2 h under gentle rotation at 4 °C. Beads were washed once
with lysis buffer and an additional three times with lysis buffer con-
taining 350 mM NaCl. Proteins were eluted in lysis buffer containing 50
mM reduced glutathione (pH 8.0), dialyzed against 25 mM HEPES pH
7.5, 150 mM KCl, 2.5 mM CHAPS, 5 mM MgCl2, 50% glycerol, ad-
justed to 60 pmol/l according to Bradford assay and stored at
80 °C.
Recombinant Protein Purification from E. coli Cultures—6xHis-
Bmh1 was expressed in BL21 STAR cells from a pET-28b() plasmid
(a kind gift from the Hahn-lab) (41). Cell were lysed in 50 mM Tris pH
7, 300 mM NaCl, 20 mM Imidazole, 2 mM -mercapto-ethanol, Com-
plete EDTA-free Protease Inhibitor Mixture, 1 g/l lysozyme by rotation
for 20 min at 4 °C and two rounds of sonication for 1.5 min. Debris
was removed by centrifugation at 20,000 rpm for 1 h at 4 °C.
Ni-NTA beads (Thermo; 88222) were washed twice in lysis buffer,
before incubation with lysate for 1 h at 4 °C. The beads were washed
three times with lysis buffer and proteins eluted with lysis buffer
containing 500 mM imidazole.
In Vitro Kinase Assay—Kinase assays were based on the method
by Asensio and Garcia with some modifications (42): Reactions were
set up by mixing 10 pmol/l kinase, 33 pmol/l Crosstide (43), 100
pmol/l ATP, 0.02 Ci/l -32P-ATP in PBS with 20% glycerol, 0.5%
Tween-20, 4 mM MgCl2, 10 mM DTT, 2 mg/ml heparin, and Complete
Protease Inhibitor Mixture w/o EDTA. After 5, 10, 17, 25, 40, 60 min at
room temperature, an aliquot was mixed with 0.5 volumes 0.5 M EDTA
with bromphenol blue.
Of the stopped reactions 5 l were spotted onto P81-paper, which
were air-dried, washed five times 10 min with 200 ml 75 mM or-
thophosphoric acid and once with acetone and dried. An imager
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screen was exposed to the filter paper for 1 h and the screen read out
using a Typhoon FLA 9500 imager (GE Healthcare).
Western Blotting—To site-specifically validate changes in Nth1
phosphorylation by Western blotting, yeast cultures were treated with
500 nM 1NM-PP1 or the corresponding volume of DMSO for 15 min
and harvested by TCA-precipitation as described for phospho-pro-
teomics sample preparation.
Yeast pellets were lysed by bead beating (5  45s at 6500 rpm) in
25 mM Tris buffer containing 6 M urea and 1% SDS. Cleared lysate
corresponding to 1.3 mg protein was diluted 1:10 in IP-buffer (50 mM
HEPES pH 7.4, 150 mM KCl, 10% glycerol containing protease-
(Roche, Basel, Switzerland) and phosphatase- (Thermo Scientific)
inhibitors and mixed with 25 l Epoxy-beads (Thermo Scientific) that
had been coupled to anti-FLAG antibody (1.5 l; Merck) in 0.1 M
sodium phosphate buffer containing 1 M ammonium sulfate at 37 °C
overnight, and washed four times with IP-buffer.
The lysate was incubated with the beads at 4 °C for 4 h, then
washed four times with IP-buffer. Proteins were eluted in 15 l Laem-
mli-buffer at 65 °C for 10 min, then in further 15 l Laemmli-buffer at
95 °C for 5 min.
The eluates from both steps were combined and resolved on a
7.5% SDS-PAGE gel. Proteins were transferred to a nitrocellulose
membrane using an iBlot2 system, blocked in 5% BSA in PBS for 1 h.
The membrane was incubated with primary antibodies (1:1000 mouse
anti-FLAG (Merck) and 1:100 rabbit anti-Nth1-S83p, a kind gift from
the Thevelein lab (25)) in 5% BSA in PBS  0.1% Tween-20 at 4 °C
overnight. It was washed four times 5 min in PBS  0.1% Tween-20,
incubated with fluorescently labeled secondary antibodies (LI-COR) in
5% BSA in PBS  0.1% Tween-20 for 30 min and washed as above.
Fluorescent signal was imaged on a LI-COR Odyssey scanner.
Trehalase Activity Assay on Permeabilized Yeast Pellets—Measure-
ment of trehalase specific activity was performed as previously de-
scribed with modifications (44). Six replicates (separate starter cul-
tures) of strains wtas, pkaas and ypk1as, as well as one sample of an
nth1-strain as a control, were inoculated in YPD (pH 5.6) and incu-
bated at 30 °C overnight. Cultures were diluted to an OD of 0.05 and
incubated for about 10 h before further dilution to OD 0.001 in YPD.
The cultures were grown to an OD of 
0.7 and, where necessary,
cultures were diluted during this time to arrive at a similar OD for all
cultures. Subsequently, 100 ml of each culture was centrifuged for 10
min at 2000  g, pellets resuspended in 10 ml YPD and distributed to
two 5 ml cultures in 50 ml Erlenmeyer flasks. The cultures were left to
recover at 30 °C with shaking at 120 rpm for 25 min before treatment
with 500 nM 1NM-PP1 (from a 250 M stock in DMSO) or the corre-
sponding volume of DMSO. After 15 min of shaking at 30 °C 0.5 ml of
each culture were harvested into 0.5 ml of 0.2 M tricine (pH 7.0) with
0.1% Triton-X 100 and 1 phosphatase inhibitor, 200 nM Okadaic
acid (Cell Signaling Technology) and 1 EDTA-free protease inhibitor
tablet (Roche) per 30 ml, immediately frozen in liquid nitrogen and
stored at 80 °C.
Samples were thawed at 30 °C in a thermomixer at 1400 rpm,
centrifuged for 1 min at 12,000  g and the pellet washed in 1 ml of
cold 0.2 M tricine pH 7.0 (1 min, 12,000  g, 4 °C). Pellets were
resuspended in 1 ml of cold 0.2 M tricine (pH 7.0) and transferred into
the wells of a deep-well 96-well plate on ice. The plate was spun for
5 min at maximum speed and 4 °C, supernatants removed, and
pellets resuspended in 320 l 62.5 mM tricine pH 7.0, 250 M CaCl2
containing protease- and phosphatase-inhibitors. A well which did
not contain a yeast pellet was used as blank. The plate and 0.5 M
trehalose were equilibrated to 30 °C for 5 min before 80 l of 0.5 M
trehalose were added to each sample and incubation at 30 °C. After
10, 20, 30, and 40 min a 25 l aliquot of each sample was transferred
into PCR-stripes and heated to 98 °C for at least 3 min.
The samples were cooled to room temperature and cell debris
spun down briefly. The amount of glucose in the supernatants was
determined using a Glucose-Oxidase/Peroxidase kit (Merck) using 5
l input in a 150 l reaction volume.
The amount of glucose generated (	 2 amount of trehalose
degraded) was determined against a glucose standard and the blank
value subtracted from each sample. The slope of the curve of treha-
lose degraded versus time after trehalose addition with y-intercept of
zero was determined as a measure for trehalase activity.
This activity was normalized to the protein level determined by BCA
assay (Thermo Scientific) after spinning the remaining samples and
bead beating of the resulting pellets in 400 l 1% SDS, 6 M urea in 25
mM Tris (pH 6.8). The trehalase activity per protein content of the
pkaas and ypk1as strains were each compared with that of the wtas
strain using a two-sided, unpaired Student’s t test.
Trehalase Activity Assays Using In Vitro Phosphorylated Nth1—
Recombinant Nth1 purified from E. coli (1 M according to Bradford
assay) was mixed with 0.5 M GST-Ypk1 purified from S. cerevisiae or
bovine PKA (Promega; V5161) and 300 M ATP in 25 mM HEPES pH
7.5, 150 mM KCl, 2.5 mM CHAPS, 5 mM MgCl2, 1 mM DTT. After 10
min at 30 °C, 12 M 6xHis-Bmh1 purified from E. coli and 30 mM
trehalose were added. Samples were incubated at 30 °C and aliquots
taken after 5, 10, 20, 30, 40 min, which were heated to 95 °C.
The amount of glucose produced was measured as described
above using 5 l of a 1:100 dilution of the samples as input.
RESULTS
Evaluation of the Chemical Genetics Approach for the Anal-
ysis of S. cerevisiae AGC-kinases—To study substrate spec-
ificities and potential signal convergence of growth-regulatory
AGC-kinases we used quantitative mass spectrometry to de-
termine changes in the yeast phospho-proteome after acute
inhibition of Sch9, PKA, or Ypk1. As overlapping functions of
PKA and Sch9 have been reported (3, 6), we also performed
simultaneous inhibition of PKASch9. Genes encoding wt
kinases were replaced with alleles encoding the correspond-
ing analog-sensitive enzymes (34). In the pkaas strains all three
PKA-paralogs (TPK1, TPK2, TPK3) were replaced with ana-
log-sensitive alleles. The YPK1 paralog YPK2, which is con-
sidered to play a minor role compared with YPK1 (16), was
deleted in all strains to avoid redundancy. S. cerevisiae strains
with analog-sensitive Ypk1 (18), Sch9 (45), and PKA (46) have
been used successfully in previous studies.
We characterized these analog-sensitive strains (denoted
as sch9as, pkaas, ypk1as, and pkaassch9as) versus the iso-
genic background (referred to as wtas) by assessing their
growth on plates with and without ATP-analog (Fig. 1 and
supplemental Fig. S2A). Given the central role of all three
kinases in growth regulation, we expected visible effects on
colony size upon the inhibition of any of them. A slight reduc-
tion of colony size was observed for the sch9as and
pkaassch9as strains even on plates without 1NM-PP1, indi-
cating that these strains were mildly hypomorphic. The sig-
nificance of this effect (p  1010) was verified independently
by measuring the sizes of individual colonies when the strains
were spread out on YPD-plates (supplemental Fig. S2B).
The strongest effect of kinase inhibition on proliferation was
seen in case of the pkaassch9as strain, which did not form
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colonies on plates containing 500 nM 1NM-PP1 (supplemental
Fig. S2A). Inhibition of Sch9 alone also exhibited a visible
reduction in growth. Interestingly, a small number of regular-
sized colonies formed under these conditions, indicating that a
limited number of cells adapted or became insensitive to Sch9-
inhibition. This is consistent with a previous observation in our
lab of an sch9-strain rapidly generating adapted clones (30).
Although less pronounced than for Sch9, the inhibition of Ypk1
also had a strong effect on colony formation on plates.
In contrast, the presence of 1NM-PP1 only mildly compro-
mised colony size in case of the pkaas strain. Therefore, the
analog-dependent inhibition of pkaas is either less efficient
than for sch9as and ypk1as or the absence of PKA activity is
compensated by other pathways in our strain background.
This second alternative seems unlikely considering the obser-
vation that tpk1 tpk2 tpk3 triple-deletion strains are not
viable (6, 8, 16). It can be envisioned, however, that there is an
increased likelihood of an adaptive response upon prolonged
exposure of an analog-sensitive strain to ATP-analog than
during creation of a deletion strain. Nevertheless, the com-
parison of the 1NM-PP1 treated sch9as and pkaassch9as
strain demonstrated that pkaas is sensitive to 1NM-PP1 (Fig. 1
and supplemental Fig. S2A) and this finding further suggested
that the compensation for PKA function is mainly through
Sch9, which is consistent with previous findings (see Broach,
2012 for a review).
PKA-, Sch9- and Ypk1-dependent Phospho-proteomes—
For phospho-proteome analyses, analog-sensitive strains
treated with 1NM-PP1 versus DMSO were compared by label-
free, quantitative shotgun proteomics.
At a false-discovery rate (FDR) of 0.01, 7575 peptides, 4628
of which were phosphorylated (61%), were identified from
phospho-peptide enriched samples from the respective
strains. These phospho-peptides corresponded to 6373
phospho-sites (at site-decoy fraction: 0.01), mapping to
1430 proteins.
Out of the 4628 identified phospho-peptides, 3113 had no
more than one missing value in three replicates of any sample
and were thus considered for further analysis (supplemental
Table S3). An overview of the data as volcano plots is shown
in Fig. 2A. It is apparent that most phospho-peptides are
unaffected by kinase inhibition. At a multiple-testing corrected
p value cut-off (pAdj) of 0.05, 439 phospho-peptides were
found to be altered in their abundance upon 1NM-PP1 treat-
ment in the Ypk1-, 128 in the Sch9-, 118 in the PKA- and 293
in the PKASch9 data set (i.e. 2.5–9.5% of phospho-peptides
were altered in the data sets). For comparison, 12 phospho-
peptides were classified as changing when wtas cells were
treated with the ATP-analog, corresponding to a 0.4% false-
positive rate.
Principal component analysis of these data revealed that
replicate samples clustered, and that separation of samples
was mainly explained by genotype rather than by treatment
(supplemental Fig. S3). Although the pkaas strain was local-
ized near wtas, the ypk1as strain on one hand and sch9as and
pkaassch9as strains on the other formed separate clusters.
With respect to the sch9as and pkaassch9as strains this
result is consistent with the observed reduced colony size of
these strains obtained in growth assays in the absence of 1NM-
PP1 (Fig. 1 and supplemental Fig. S2B). This again suggests
that the gatekeeper mutation in Sch9 reduces the catalytic
activity of this kinase and renders the strains hypomorphic. In
contrast, we did not observe impaired colony formation of the
ypk1as strain. This indicates that the extent of reduced phos-
phorylation of Ypk1 targets in this hypomorphic strain is not
enough to lead to an observable proliferation phenotype.
We argued that the observed hypomorphic phenotypes
were because of reduction of kinase activity by the gate-
keeper mutations. Indeed, GST-tagged analog sensitive Ypk1
and Sch9 purified from yeast displayed a reduced activity in
an in vitro kinase assay compared with the respective wt
versions (supplemental Fig. S2C).
A heatmap depicting the intensity fold changes of peptides
significantly (pAdj  0.05) hypo- or hyper-phosphorylated upon
kinase inhibition is shown in Fig. 2B. This global overview sug-
gests a similar pattern of changes in the PKASch9, Sch9 and
PKA data sets, albeit for some phospho-peptides changes are
only apparent in the PKASch9 data set. In contrast, the Ypk1
data set contains some phospho-peptides which change in the
same direction as in one or more of the other data sets, but the
majority appears to change uniquely in this sample.
To further assess the commonalities and differences be-
tween the inhibition of these kinases we determined the over-
lap among significantly (pAdj  0.05) altered phospho-pep-
tides observed for each strain tested (supplemental Fig. S4A).
We first asked whether our data would recapitulate the
previously reported interaction between PKA and Sch9 sig-
naling in the form of shared targets (3). Indeed, one third to
one half of the phospho-peptides significantly affected (i.e.
hyper- or hypo-phosphorylated) in one of the data sets was
also significant in the other (50 out of 117 and 128 respec-
tively). This may indicate a strong overlap of, or cross-talk
between, the signaling pathways. In the former case it can be
envisioned that for some shared targets the inhibition of one
FIG. 1. Inhibition of AGC-kinases inhibits colony formation to
varying extents. Analog-sensitive strains as indicated were spotted
on YPD plates containing DMSO or 500 nM 1NM-PP1 in 10x serial
dilutions and imaged after 2 days at 30 °C.
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of the inputs is compensated by the other. An argument in
favor of this proposition is the finding that approximately twice
as many significant phospho-peptides (293) were identified in
the PKASch9 data set compared with the individual PKA
and Sch9 data sets. Furthermore, 112 of these were unique to
the PKASch9 data set, consistent with the notion that wild
type PKA or Sch9 masks the loss of the other for many
targets. On the other hand, 80% of the Sch9- and 66% of the
PKA-targets were significantly altered also in the PKASch9
data set, arguing that the high number of sites unique to
PKASch9 is not merely because of failure to detect true
positives repeatedly over data sets.
We next addressed the overlap between PKA/Sch9- and
Ypk1-targets, which we expected to be low as TORC2-sig-
naling is less connected to PKA- and Sch9-signaling than the
latter two to each other. Consistent with this idea, we found
297 phospho-peptides uniquely affected by Ypk1 inhibition.
Surprisingly, 142 phospho-peptides (32%) were shared with
at least one other data set, especially with PKASch9 (27%).
The results were qualitatively similar when focusing only on
hypo- (supplemental Fig. S4B) and hyper-phosphorylated
(supplemental Fig. S4C) phospho-peptides, in that targets
unique to the Ypk1- and PKASch9-data sets constituted the
largest groups whereas a strong prevalence of phospho-
peptides shared between sets was also apparent.
A full list of gene ontology (GO) terms significantly enriched
(p  0.05) among proteins with regulated phospho-sites is
given in supplemental Table S4. Among the Biological Proc-
ess GO terms, “endocytosis.” which was enriched in the
Ypk1-data set, is a major downstream process regulated by
this kinase (47). Indeed, the majority of the 65 proteins asso-
ciated with this term form an interconnected network with
Ypk1 that contains key proteins from several stages of endo-
cytosis (initiation: Syp1, Ede1; budding: Pan1, Las17, Ent1,
Ent2; and coat disassembly: Inp52) (supplemental Fig. S5)
(48). It should be noted that many of these proteins likely are
not direct Ypk1 targets, but connected further downstream in
the Ypk1-Fpk1-Dnf1/Dnf2-Akl1 axis (supplemental Fig. S5)
(48). Beyond these fundamental endocytic steps, proteins
involved in cargo recruitment (Bul1, Ecm21, Rod1, Aly1, and
Aly2) were also found to be affected by Ypk1 inhibition. Inter-
estingly, the nutrient permease regulator Npr1 forms part of
this network, even though it previously had been associated
with TORC1 rather than TORC2 signaling (49).
“Regulation of transcription involved in meiotic cell cycle”
and “Response to abiotic stimulus” were both enriched in the
PKA-, whereas no significant terms were found for the Sch9-
and PKASch9-data sets.
Similar gene ontologies related to transferase/glucosyl-
transferase activity were detected for the PKA, Sch9 and
PKASch9 data set and the proteins associated with these
GO-terms in the three data sets strongly overlapped and
included subunits of the trehalose 6-phosphate/phosphatase
complex (Tsl1 and Tps3), glycogen phosphorylase Gph1 and
glycogen synthases Gsy1 and Gsy2 (supplemental Table S4).
The fact that both homologs Gsy1 and Gsy2 were detected
based on distinct peptides lends validity to the finding that the
regulation of storage carbohydrate metabolism is an impor-
tant function of PKA and Sch9 signaling (supplemental Table
S3). Additionally, the neutral trehalase Nth1 was found to be
affected by PKA and Ypk1 inhibition (see below).
In summary, we observed that all the analog-sensitive ki-
nases were affected by 1NM-PP1 addition based on the
growth of the corresponding strains and on observed
changes in protein phosphorylation. These phosphorylation
changes are consistent with previous knowledge, especially
with respect to the close connection between PKA- and
Sch9-signaling. Additionally, enriched GO-terms reflect pre-
vious data, but are represented also by additional proteins
that had not been linked to the respective kinases.
Sequence Motifs—To determine if AGC-kinases in our ex-
periments preferentially targeted specific amino acid se-
quences, we generated logos of the sequences surrounding
phospho-sites significantly affected by 1NM-PP1 treatment.
This was done individually for up- and down-regulated sites
and for a combination of both for each of the four data sets
(Fig. 3).
A clear enrichment of arginines in the -2 and -3 position of
residues hypo-phosphorylated upon the inhibition of any of
the kinases was observed. The motifs of the PKA, Sch9 and
PKASch9 data sets closely resembled each other in this
respect and exhibited stronger enrichment of arginine in the
-2 than -3 position. These findings are consistent with the
reported RRxS/T consensus motif for PKA and Sch9 and may
therefore reflect the presence of direct targets of the studied
kinases (50, 51).
For hypo-phosphorylated sites in the Ypk1-data set in con-
trast, arginine was more strongly enriched in the -3 position
and further enrichment of arginines N-terminal of the phos-
phorylated residue, at -5 and -2, could be observed. The
sequence context determined for Ypk1 fitted the reported
RxRxxS/T-motif because of the enrichment of arginine in the
-5 and -3 position (52), however additionally an unexpectedly
high frequency of arginine in the -4 and especially -2 position
was apparent in our data. As Ypk1 is a major target of TORC2,
we compared this motif to the sequence motif of sites found
FIG. 2. Phosphorylation changes upon AGC-kinase inhibition. A, Volcano-plots depicting log2-fold-changes (mean of three replicates)
versus adjusted p values for intensities of all quantified phospho-peptides in 1NM-PP1 versus DMSO treated samples. Density is color-coded
according to legend. B, Heatmap depicting mean values for three replicates of log2-fold changes in phospho-peptide intensities for 1NM-PP1
versus DMSO treated samples. Data of phospho-peptides significantly (pAdj  0.05) hyper- or hypo-phosphorylated upon inhibition of at least
one kinase in the PKASch9, PKA, Sch9 or Ypk1 data set are shown. Bargraphs of normalized intensities for three selected phospho-peptides
are shown to the right.
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hypo-phosphorylated upon TORC2-inhibition in a previous study
(36). A strong prevalence of arginines in the -5, -3 and -2 positions
was also observed in this data set (supplemental Fig. S6), which
argues that the sequence specificity of Ypk1 was not altered
because of the gatekeeper mutation.
It is noteworthy that a slight enrichment of arginine in the -3
position of sites hyper-phosphorylated upon kinase inhibition
was observable. As the change in abundance was opposite to
what was expected for direct targets, it is possible that this
residue forms part of the recognition sequence of a kinase
that is itself repressed by the analog-sensitive kinases
studied.
In each case, the PKASch9 motifs constituted a more
pronounced version of the PKA and Sch9 motifs, therefore
indicating that Sch9- and PKA-signaling converge either
through shared targets or cross-talk.
Phosphorylation Levels of Known Direct AGC Kinase Tar-
gets—To estimate if our approach was suitable to identify
direct AGC-kinase targets we asked how many of their pre-
viously known target-sites were identified and exhibited sig-
nificant down-regulation upon kinase inhibition in our data set.
Ypk1, Sch9 and PKA target sites derived from the literature
are listed in supplemental Tables S5A–S5C.
Although only 14% to 19% of bona fide kinase target sites
were detected (i.e. identified and quantified) by mass spec-
trometry, most of these sites were significantly hypo-phos-
phorylated upon inhibition of the respective kinase:
Three of the 21 known Ypk1 target sites were detected in
this study and all found to be down-regulated upon Ypk1-
inhibition (Lag1 S24, Gpd1 S24, Rod1 S138; Fig. 4). Similarly,
two of the 13 known Sch9 target sites were detected here and
both were down-regulated in the Sch9 and the PKASch9
data sets (Stb3 S254, Maf1 S90; Fig. 4). Finally, six of 31 bona
fide PKA-sites were detected and three of them were down-
regulated in the PKA (Bcy1 S145, Nth1 S60, Nth1 S83) and six
in the PKASch9 (Bcy1 S145, Nth1 S60, Nth1 S83, Maf1 S90,
Pat1 S456 and Pat1 S457) data set (Fig. 4).
Therefore, although our phospho-proteomics data suffered
from the high false negative rate with respect to detection,
typically associated with this approach, the quantitative ac-
curacy appeared sufficient to detect biologically meaningful
changes.
Many Proteins Possess More Than One Regulated Phos-
pho-site—Several of the previously reported AGC-kinase tar-
gets (e.g. Fpk1, Orm1, Fps1, Stb3, Maf1, and Rim15) harbor
more than one regulated phospho-site (supplemental Table
S5A to S5C) (53–58). We therefore asked if this feature could
also be observed in our study. Site-specific quantification of
phosphorylation levels can be complicated by several sites
residing on the same phospho-peptide as it may not be clear
FIG. 3. AGC-kinase target sites are
located in basic sequence motifs. Se-
quence motifs from -5 to 5 amino ac-
ids surrounding serines and threonines
significantly (Padj  0.05) affected by in-
hibition of PKA, Sch9, PKASch9 and
Ypk1 (left to right). Top to bottom rows:
Union of hyper- and hypo-phosphoryl-
ated, hyper-phosphorylated, hypo-
phosphorylated sites. Red horizontal
lines indicate over- and underrepresen-
tation at p 	 0.05.
FIG. 4. Detected bona fide kinase target sites are largely found hypo-phosphorylated upon kinase inhibition. Venn diagrams depicting
the number of bona fide target sites of the kinase indicated (red), subset of these sites detected by phospho-proteomics (green) and subset
of these exhibiting significant (pAdj  0.05) hypo-phosphorylation (purple). Blue circles indicate a complete overlap of the two subsets.
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which site is responsible for an observed change in phospho-
peptide abundance. Furthermore, sites located near lysine or
arginine may impede tryptic cleavage and distort the quanti-
fication of nearby residues. We therefore used the presence of
arginine in the -3 position from the phosphorylated residue,
which is a frequent feature of target sites of the AGC-kinases
under investigation, as an additional criterion for selecting
proteins with multiple regulated sites (21, 59).
Notable observations included the detection of two regu-
lated RxxS-sites on the previously reported Sch9-target Stb3
in the Sch9 and PKASch9 data sets (56). We also observed
two and three regulated phospho-sites on the protein kinase
Ksp1 in the Sch9 and PKASch9 data sets respectively, one
of which (S624) was also significant in the Ypk1 data set.
Additionally, S884-phosphorylation on this protein was only
affected upon Ypk1-inhibition. In the Ypk1 data set, only a few
of the RxxS/T-sites on multi-site proteins were found in the
strict RxRxxS/T-motif ascribed to Ypk1 (59). Instead, several
of the multi-site proteins were shared with other data sets,
including Smy2, Gcs1, Igo2, Ksp1, and Avt1 (supplemental
Table S3).
Similarly, several of the regulated RxxS/T-sites on multi-site
proteins in the PKA data set were found in relaxed motifs, i.e.
without a basic residue in the -2 position, but with a proline at
1 (T70 and S96 on Smy2; T161 and T170 on Gcs1; S135,
S147, and S161 in Tsl1). Interestingly, four regulated phos-
pho-sites were detected on the trehalose synthase subunit
Tsl1 in all four data sets.
Finally, three RxxS phospho-sites on Bcy1 were signifi-
cantly affected in the PKA and PKASch9 data sets. Phos-
pho-peptides containing either S83 or S145 exhibited an

45–75% reduced abundance upon kinase inhibition in both
data sets, whereas phospho-peptides with T129 showed an
up to 2-fold increase in the PKA data set.
As Bcy1 is the common regulatory subunit of all three
catalytic PKA-subunits (Tpk1, Tpk2 and Tpk3), it is conceiv-
able that these sites form part of a feedback loop regulating
PKA activity. Indeed, S145 has previously been reported as a
PKA target as part of its negative feedback mechanism (60).
The same study identified S145 as the by far major target of
PKA on Bcy1, which is consistent with this site being the only
RRxS/T-site in the protein. The other sites determined in our
study may therefore be targets of other kinases or weaker
PKA-targets.
We did not detect any peptides on phospho-diesterase
Pde1, which has been reported as another component of
cAMP-signaling that is a target PKA (61). Instead, S534 and
S631 on Ras GTPase activating protein Ira2 were significantly
altered in their phosphorylation state upon PKA inhibition and
may therefore constitute a so far unknown feedback mecha-
nism of PKA.
The reason for the clustering of phosphorylation-sites on
AGC-kinase targets is not well understood in most cases, but
it may allow generating switch-like responses similarly to
other kinase targets (62). In any case, the discovery of multiple
sites within certain proteins, which are affected by kinase
inhibition suggests that the function of these proteins is reg-
ulated by said kinase.
Phospho-sites Within Kinase Consensus Motifs—As de-
scribed above, we observed a strong enrichment of arginine
in the -3 position of phospho-peptides significantly hypo-
phosphorylated upon inhibition of any of the kinases tested.
Indeed, of the 484 identified phospho-sites within a RxxS/T-
motif, 117 were significantly (Padj  0.05) hypo-phosphoryl-
ated in at least one of the data sets. Because this is consistent
with previously reported kinase consensus motifs (RRxS/T for
Sch9 and PKA and RxRxxS/T for Ypk1) (51, 59), we argued
that the corresponding sites may constitute potential direct
kinase substrates. We asked if these potential direct targets
are shared between kinases tested or specific to individual
kinases.
Like the data on all hypo-phosphorylated sites, the vast
majority of RxxS/T-sites in the PKA or Sch9 data set were also
part of the PKASch9 set. Not all of these sites overlapped
between the PKA and Sch9 samples, indicating that they may
be targets of only one of the two kinases or that inhibition of
one kinase targeting a site is compensated by the second
kinase (Fig. 5A).
Although 45 RxxS/T-sites were uniquely affected by Ypk1-
inhibition, 36 sites were also hypo-phosphorylated in at least
one other data set. As the Ypk1 consensus motif is distinct
from the PKA/Sch9 motif, we asked if this overlap mainly
comprised sites within RRxS/T- or RxRxxS/T-motifs.
We therefore evaluated the overlap of significantly hypo-
phosphorylated RxRxxS/T and RRxS/T sites between data
sets (Fig. 5B and 5C). As expected, the majority of RxRxxS/
T-sites (20 of 24) were unique to the Ypk1-set. Consequently,
sites with an RxRxxS/T-motif do not explain the overlap of
RxxS/T-sites between the Ypk1 and the other three data sets.
On the other hand, 31 RRxS/T-sites were hypo-phosphor-
ylated in the Ypk1 data set, of which 24 overlapped with at
least one of the other sets (Fig. 5C). Among these 31 sites only
four were simultaneously in an RxRxxS/T-motif (i.e. RxRRxS).
Assuming these sites are indeed direct Ypk1 targets, the
previously defined Ypk1 consensus motif of RxRxxS/T may
need to be reconsidered.
We next asked if the RRxS/T-sites that are potential Ypk1
targets had any other sequence characteristics close to the
phospho-site, but no obvious amino acid enrichments at
other positions within five residues from the phospho-site
were observed (supplemental Fig. S7).
Following the unanticipated observation that Ypk1 affects
the phosphorylation state of sites presumed to be PKA-
and/or Sch9-targets based on our results and their sequence
context, we next aimed to validate this observation on a
selected candidate protein.
Nth1 Phosphorylation of S83 is Positively Regulated by PKA
and Ypk1—Our phospho-proteomics assay detected a phos-
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pho-peptide (81RGSEDDTYSSSQGNR95  phos) of neutral
trehalase Nth1 with potential phosphorylation at S83 or T87
(or a mix of both), down-regulated with a fold-change (FC) of
0.6 (p 	 0.007), 0.5 (p 	 0.009) and 0.3 (p 	 4  105) on
Ypk1, PKA and PKASch9 inhibition respectively. A second
phospho-peptide of Nth1 mapping to S60 (58TMSVFDNVSP-
FKK70  phos) exhibited significant down-regulation upon
Ypk1 (FC 	 0.4; p 	 0.0004), PKA (FC 	 0.5; p 	 0.01) and
PKASch9 (FC 	 0.5; p 	 0.02) inhibition.
Nth1 is a commonly cited model-substrate of PKA and its
trehalase activity is increased by PKA-dependent phosphor-
ylation of its N-terminal tail (28, 63, 64).
In contrast, although Ypk1 had previously been shown to
regulate metabolic functions, including of enzymes influencing
the levels of the osmo-protective metabolite glycerol, the regu-
lation of the major thermo-protective metabolite trehalose has
not been reported (65, 66). To validate our phospho-proteomics
results we asked whether Ypk1-inhibition would alter the phos-
phorylation of an RRxS-site (S83) on Nth1, whose phosphoryl-
ation had previously been attributed to PKA (25, 64).
We evaluated the phosphorylation of this site on endoge-
nously 3xFLAG-tagged Nth1 after immuno-affinity purification
by Western blotting with an antibody against phosphorylated
S83 (S83p) (25). Indeed, the signal was reduced upon 1NM-
PP1 treatment of strains harboring either analog-sensitive
Ypk1 or PKA (Fig. 6). Importantly, no signal remained in the
absence of both enzymatic functions. We also tested the
phosphorylation of S83 upon Ypk1, PKA and Ypk1PKA
inhibition in an independent experiment using a targeted pro-
teomics assay. The results closely agreed with the ones ob-
tained by Western blotting and confirmed that S83, and not
T87, was the phosphorylated residue (Fig. 7A and 7B).
These findings validate the effect of Ypk1 on phosphoryla-
tion of a site located within an RRxS-motif and therefore not
assumed to be a direct Ypk1 target based on its previously
reported consensus motif (59).
Nth1 is Activated in a PKA- and Ypk1-dependent Man-
ner—It has been previously reported that the PKA-dependent
phosphorylation of the N-terminal tail of Nth1 stimulates the
enzyme’s trehalase activity (24, 25, 28). Based on our results
of Ypk1-dependent phosphorylation of Nth1 we asked if Ypk1
would also regulate Nth1 activity.
For this we again compared wtas, pkaas and ypk1as strains
treated for 15 min with 1NM-PP1 with mock-treated controls
and assessed trehalase activity by a method similar to the one
described by De Virgilio, 1991 (44).
We employed a nth1 strain as a control in this experiment.
For this strain no detectable trehalase activity could be ob-
served (supplemental Fig. S8A and S8B) indicating that Nth1 is
the only trehalase active under these conditions. Note that acidic
trehalase is not expected to be active at the neutral pH used for
FIG. 5. Overlap of hypo-phosphorylated sites associated with kinase consensus motifs between kinase inhibition data sets.
Venn-diagrams represent phospho-sites significantly (pAdj  0.05) hypo-phosphorylated upon inhibition of PKA, PKA  Sch9, Sch9 or Ypk1
in RxxS/T- (A), RxRxxS/T- (B) and RRxS/T- (C) motifs.
FIG. 6. Western blotting demonstrates dephosphorylation of
Nth1 S83 upon inhibition of PKA, PKAYpk1 and Ypk1. Strains
wtas, pkaas, pkaasypk1as and ypk1as harboring endogenously C-ter-
minally 3xFLAG tagged Nth1, the corresponding isogenic wt strain
with 3xFLAG-tagged nth1-S20A,S21A,T58A,S60A,S83A (wtas nth1–
5A-3xFLAG) and untagged isogenic wt strain (wtas) were treated with
DMSO or 500 nM 1NM-PP1 for 15 min. Eluates from immuno-precip-
itates with an anti-FLAG antibody were probed with antibodies
against S83p and against the FLAG-tag.
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this assay. We observed that trehalase activity was strongly
reduced in the pkaas, and somewhat also in the ypk1as strain,
even in the absence of 1NM-PP1, indicating the hypomorphic
nature of these strains (supplemental Fig. S8A and S8B). Im-
portantly, a significant reduction of trehalase activity in both
analog-sensitive strains was observed upon 1NM-PP1 addi-
tion relative to mock treated controls (p 	 6  106 and 1 
105 respectively; Fig. 8, supplemental Fig. S8A and S8B).
This indicates that, as for PKA, Nth1-activity was positively
regulated in a Ypk1-dependent manner.
Finally, we tested if Ypk1 can activate Nth1 in a direct
manner. To this end, we incubated Nth1 with GST-Ypk1 and
ATP before measuring trehalase activity. Indeed, similarly to
PKA, GST-Ypk1 strongly induced trehalase activity (Fig. 9).
This increase in activity was dependent on the presence of
Bmh1, a 14–3-3 protein reported to bind phosphorylated
Nth1, as previously reported (63).
It can therefore be envisioned that stresses inactivating
Ypk1 contribute to trehalose accumulation. Vice versa, return
to favorable growth conditions and re-activation of Ypk1 may
contribute to trehalose degradation by Nth1. Lastly, basal
Ypk1 activity appears to contribute to basal Nth1 activity in
exponentially growing cells.
DISCUSSION
Previous Studies on AGC-kinase Functions—In this study
we investigated the targets of three major growth-regulatory
AGC-kinases in S. cerevisiae, PKA (Tpk1, Tpk2, Tpk3), Sch9
and Ypk1. For this purpose, we employed analog-sensitive
versions of these kinases in combination with phospho-pro-
teomics. A ypk1 ypk2 double- and tpk1 tpk2 tpk3 triple-
deletion renders cells inviable and deletion of SCH9 leads to
severe phenotypic effects, demonstrating the important roles
that these kinases perform (6, 8, 16). A previous large scale
phospho-proteomics investigation of strains in which individual
kinases had been disrupted included tpk1, tpk2, tpk3,
ypk1, and ypk2 strains (22). Of necessity, this approach
precluded the study of strains harboring co-deletions of essen-
tial paralogs. A further disadvantage of using deletion strains for
studying an enzyme is that such strains inevitably adapt in ways
that often mask effects on direct targets.
Analog-sensitive strains of AGC-kinases have been de-
scribed previously, but not to determine the effect of their
inhibition on global phosphorylation changes (17, 45, 67). We
reasoned that the acute inhibition of kinases via a chemical-
genetics strategy in combination with a direct readout of
phosphorylation changes should enable us to increase our
understanding of signaling downstream of these kinases and
in particular identify novel direct targets.
Interplay Between Sch9- and PKA-signaling—There is am-
ple genetic evidence for a close link between PKA- and Sch9-
dependent signaling (3). In fact, Sch9 was identified as a high
copy suppressor of a temperature sensitive mutation in the
FIG. 7. Parallel reaction monitoring demonstrates dephosphorylation of Nth1 S83 upon inhibition of PKA, PKAYpk1 and Ypk1. A,
Extracted ion chromatograms of transitions of seven site-determining ions (i.e. ions not shared with other potential phospho-isoforms) of
80RGS(ph)EDDTYSSSQGNR94 (precursor 580.2270; z 	 3) were extracted from a PRM-experiment on phospho-peptides from strains treated
with DMSO or 500 nM 1NM-PP1 for 15 min. Three replicates were analyzed per condition. B, Barplot depicting weighted-mean intensities of
phospho-peptides corresponding to Nth1 S83p shown in A. Indicated strains were treated with DMSO (gray) or 500 nM 1NM-PP1 (orange) for
15 min. Bars represent averages from three replicates and errorbars represent standard error of the mean. Asterisks indicate significant fold
changes at p values less than 0.05.
FIG. 8. Inhibition of PKA and Ypk1
leads to reduced Nth1 activity. Barplot
depicting trehalase activity of 1NM-PP1
treated wtas, pkaas and ypkas strains rel-
ative to activity of corresponding DMSO-
treated strains. Strains were in exponen-
tial growth phase and treatment was for
15 min. Error-bars depict standard devi-
ation of six replicates. Reduction of rel-
ative trehalase acitivity in pkaas and
ypk1as strains is significant with p 	 6 
106 and p 	 1  105 respectively.
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Ras2-guanine nucleotide exchange factor Cdc25 (6). On the
flip-side, Sch9 exhibits synthetic lethality with components of
the PKA-pathway, Gpr1, Gpa2, and Ras2 (68–70). Signaling
through the PKA-pathway represses stress-protective activi-
ties of Yak1 and Msn2/4 and G0-entry via Rim15. The sub-
sequent heat-shock sensitivity of an activating mutation in
GPA2 is suppressed by deletion of SCH9 (71).
Consistently, we observed a strong overlap of phospho-
sites affected by PKA- and Sch9-inhibition. Further, a high
number of sites detected only upon simultaneous inhibition of
both kinases may comprise further shared sites for which the
activity of one kinase masks the inhibition of the other. The
consensus sequence detected for both kinases closely re-
sembles their established RRxS/T-motif (51, 72, 73).
These observations pose fundamental questions for future
research: Is the considerable overlap between sites affected
by PKA and Sch9 inhibition because of cross-talk between
the two signaling pathways or because of shared targets of
the two kinases? In case of targets unique to one of the kinases,
how is this selectivity established, considering the high similarity
of the PKA- and Sch9-consensus motifs? The data provided in
this study serves as a starting point to answer these questions.
Interplay Between Ypk1- and PKA/Sch9-signaling—Al-
though evidence for an overlap between PKA- and TORC1-
Sch9-signaling had been reported, TORC2-Ypk1-signaling is
considered to be distinct from the former two pathways.
Despite shared subunits between the TOR-complexes,
TORC1 is believed to mainly respond to nutritional cues
whereas TORC2 receives its input primarily from the cell
membrane (74) as well as glucose (19).
Several findings in this study tie Ypk1 much more closely to
PKA and Sch9 than we previously assumed: whereas many
phospho-peptides were affected uniquely upon Ypk1 inhibi-
tion, a surprisingly high number overlapped with the other
data sets. Second, although the Ypk1 consensus motif de-
rived in this study was consistent with the previously reported
RxRxxS/T-motif, a clear enrichment of arginine in the -2 po-
sition could be observed. Closer investigation of basophilic
sites hypo-phosphorylated upon Ypk1 inhibition revealed two
nearly mutually exclusive sets of Ypk1 targets: one set of sites
associated with the RxRxxS/T-motif and almost uniquely af-
fected by Ypk1-inhibition and the other of sites associated with
the RRxS/T-motif and largely shared with at least one other
kinase. These observations suggest that Ypk1 recognizes two
related, but distinct motifs. Alternatively, Ypk1 may regulate
these sites indirectly through an RRxS/T-specific kinase.
We detected 92 phospho-sites within RRxS/T-motifs out of
1041 such sites in the iPTM-database (75) (and 1241 occur-
rences of the motif in the yeast proteome). Thus, a sharper
picture may emerge if data on these missing sites is acquired.
Beyond the incomplete nature of any phospho-proteomics
study, it is possible that the choice of trypsin as a protease is
a limiting factor as phospho-peptides originating from basic
sequence contexts may frequently be too small for reliable
identification by MS. Although the use of trypsin may there-
fore cause blind-spots, it is not expected to bias the observed
motifs as they were constructed against a background of all
peptides quantified in this study.
Kinase Target Motifs—The commonly cited Ypk1 target
motif is RxRxxS/T (with an additional preference for a hydro-
phobic residue in the 1 position) and was defined by the
Thorner lab based on nine bona fide Ypk1 target sites on five
proteins and previously published in vitro assays on synthetic
peptides (46). This resembles the consensus motif of the
presumed human homolog of Ypk1/2, SGK (21). It is interest-
ing to note that, although one of the in vitro studies to define
the Ypk1 target motif did not test peptides containing the
RRxS/T-sequence (51), the second reported a Ypk1 motif
similar to our study: whereas arginine in the -3 position was
most strongly enriched, a similar prevalence of arginine in -5
FIG. 9. PKA and GST-Ypk1 each ac-
tivate Nth1 trehalase activity in pres-
ence of 6xHis-Bmh1. Recombinant Nth1
was incubated with ATP and GST-Ypk1
or PKA as indicated, before addition of
trehalose and 6xHis-Bmh1 as indicated.
Trehalase activity was determined by
measuring the amount of glucose pro-
duced over time.
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and -2 was also observed (51, 72). Parenthetically, for Ypk2
the target sequence even more closely resembled an RRxS/
T-motif (72). Collectively, these results suggest that Ypk1 also
recognizes RRxS/T-motifs besides RxRxxS/T.
After the initial definition of the Ypk1 consensus motif (52)
12 further sites on six proteins were identified, which all reside
in RxRxxS/T-motifs (52, 52, 55, 76). However, the presence of
this motif in each case constituted a criterion in the search for
new Ypk1 sites, biasing the selection.
It should also be noted that the assays performed in our
study targeted Ypk1 during conditions of basal activity rather
than in contexts where it is highly activated. It may be spec-
ulated that full activation of Ypk1 leads to a change in its
substrate preference. This idea is particularly intriguing as
distinct phosphorylation steps by Pkh1/2 and TORC2 may
lead to partial and full activation of Ypk1 (14, 21).
In contrast to Ypk1, the sequence motif for sites hypo-
phosphorylated upon PKA-inhibition closely agrees with the
previously reported PKA-consensus motif. Similarly, our
Sch9-motif is in agreement with a motif previously defined by
peptide-array (51) and with the fact that bona fide Sch9 target
sites are generally in an RRxS/T-motif (2, 30, 56).
Regulation of Trehalose Metabolism by Ypk1—We further
investigated the connection between PKA- and Ypk1-signal-
ing by choosing neutral trehalase Nth1 as an example. The
phosphorylation of its N-terminal tail (S20, S21, S60 and S83)
by PKA has been previously reported (25, 28, 64). It has been
suggested that this phosphorylation leads to the activation of
its trehalase activity, mainly through the binding of 14-3-3
proteins to phosphorylated S60 and S83 (63, 64). We here
showed that Nth1 phosphorylation and activity is also dimin-
ished by Ypk1 inhibition in vivo and that Nth1 is activated by
Ypk1 in vitro, therefore establishing a connection between
TORC2-signaling and storage carbohydrate metabolism.
Few Ypk1 targets are currently known. Regulation of treha-
lose metabolism may therefore be a so far overlooked
TORC2-dependent stress response. If this regulation is in-
deed via direct phosphorylation of the N-terminal tail of Nth1
by Ypk1, remains to be determined. The fact that two of the
presumed regulatory sites, S20 and S60, reside within an
RxRxxS/T-sequence, the classical Ypk1 target motif, argues
in favor of this possibility, regardless of if Ypk1 can also
phosphorylate RRxS/T-sites.
Based on the finding that trehalose prevents the aggrega-
tion of partially unfolded proteins, but also interferes with their
re-folding, it has been proposed that rapid activation of tre-
halase in heat-shock recovery is important to restore protein
function (27). We speculate that activation of trehalase by
Ypk1 may be primarily of importance under conditions when
PKA activity is low, but to date failed to demonstrate this
physiological role. Alternatively, activation of Nth1 may be a
combined function of phosphorylation by PKA and Ypk1. This
proposition is attractive because of the presence of preferred
PKA and Ypk1 sites in the Nth1 N-terminal tail, according to
their classical consensus motifs.
Further phospho-sites on trehalose-6-P synthase/phos-
phatase subunits Tsl1, Tps2 and Tps3 were affected by Ypk1
inhibition and may provide further ways for TORC2-signaling
to modulate trehalose metabolism.
The TORC2-dependent regulation of endocytosis in con-
trast is well-established, however mechanistically not well
understood (47). Our data provide an extensive list of Ypk1-
regulated phospho-proteins involved at several steps of en-
docytosis. It will be interesting to map the location of these
proteins in the TORC2-Ypk1 pathway and to define pheno-
typic consequences of site-specific mutants of the corre-
sponding phospho-sites.
Finally, we reported phospho-sites affected by the inhibi-
tion of AGC-kinases on proteins that had not been previously
linked to signaling through these kinases. Based on the close
match of sequence motifs derived from these sites and the
reported consensus motifs of the kinases it is likely that we
detected several direct kinase targets, setting the stage for
future focused studies.
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